Giredestrant Reduces Recurrence Risk More Than Tamoxifen, Aromatase Inhibitors - lidERA Trial

Thanks for sharing arpie​ - really interesting and encouraging research. It’s great to see consistent findings across studies in other countries, as that broader evidence can really help influence future treatment guidelines.